Key statistics
On Friday, Evaxion A/S (EVAX:NAQ) closed at 3.34, 178.33% above the 52 week low of 1.20 set on Apr 10, 2025.
52-week range
| Open | 3.19 |
|---|---|
| High | 3.39 |
| Low | 3.19 |
| Bid | 2.86 |
| Offer | 5.00 |
| Previous close | 3.19 |
| Average volume | 52.93k |
|---|---|
| Shares outstanding | 158.48k |
| Free float | -- |
| P/E (TTM) | -- |
| Market cap | 26.47m USD |
| EPS (TTM) | -16.88 USD |
Data delayed at least 15 minutes, as of Feb 13 2026 21:00 GMT.
More ▼
Announcements
- Evaxion expands AI-Immunology™ platform into autoimmune diseases
- Evaxion to present 2026 company milestones at Biotech Showcase conference in San Francisco next week
- Evaxion provides update on MSD collaboration - retains global rights to Gonorrhea vaccine candidate EVX-B2
- Evaxion presents new data for EVX-04, a cancer vaccine candidate for acute myeloid leukemia at ASH Annual Meeting
- Evaxion announces positive data for lead antigens in cytomegalovirus (CMV) vaccine program EVX-V1
- Evaxion announce 2026 financial calendar
- Evaxion presents new immune data from phase 2 trial with AI-designed personalized cancer vaccine EVX-01
- Evaxion announces business update and third quarter 2025 financial results
- Evaxion expands R&D pipeline with new AI-designed precision cancer vaccine candidate
- Correction: Evaxion to announce business update and third quarter 2025 financial results on November 6, 2025
More ▼
